Laparoscopy

AAGL to Host Global Congress on Minimally Invasive Gynecologic Surgery, December 1-4, 2022

Retrieved on: 
Wednesday, October 19, 2022
Aurora, Linda, Physician, Panel discussion, Congress, Veteran Access to Care Act of 2014, Narration, Marketing, Robotics, Continuing medical education, Woman, Education, CME, National Primate Research Exhibition Hall, Administrator of the United States Agency for International Development, Distinguished Service Award, AAGL, Research, Program, Foundation (nonprofit), Learning, Convention, Industry, American Association, Association, Safety, State, Pelvic pain, USAID, Court of general sessions, Surgeon, Communications manager, Rockefeller Foundation, Birth control, Pharmaceutical industry, Management, Laparoscopy, Oncology, Endometriosis, Hysteroscopy, MIGS

CYPRESS, Calif.,  October 19, 2022 /PRNewswire-PRWeb/ -- AAGL Global Congress registration is filling at a record-breaking pace as the global association prepares to welcome physicians from all over the world online and at the Gaylord Rockies Convention Center in Aurora, Colorado, USA. The theme of this year's Global Congress, "Dissemination of MIGS Care: Improving Access for All" captures AAGL's global vision to combine the wealth of experience of our worldwide physicians and best identify ways to improve access to quality MIGS care for all women, including those in underserved populations.

Key Points: 
  • The American Association of Gynecologic Laparoscopists (AAGL) announces the 51st Global Congress on Minimally Invasive Gynecologic Surgery (MIGS), December 1-4, 2022.
  • "The 2022 AAGL Global Congress is an incredible opportunity for learning and collaborating with colleagues from across the globe to advance progress in minimally invasive gynecologic surgery and to improve access to quality healthcare for all women."
  • As in years past, the AAGL Global Congress on MIGS is the premier academic event of the year for personal and professional development in Minimally Invasive Gynecologic Surgery.
  • 2022 AAGL Global Congress Highlight Video: https://youtu.be/tnfv5I1LLLg
    AAGL is an international professional medical association of laparoscopic surgeons and the global leader in minimally invasive gynecologic surgery.

Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound

Retrieved on: 
Friday, October 7, 2022
Quality of life, Pancreatic cancer, Sale, Observation, 3D ultrasound, Diagnosis, Olympus, Neoplasm, Endoscopy, Laparoscopy, Patient, Twitter, Malignancy, Mortality, Cancer, Technology, Solution, Lung cancer, Stomach, EUS, Bile, Pancreas, Esophagus, Pancreatitis, Medical device, Medical imaging

TOKYO & HAMBURG, Oct 7, 2022 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, today announced the launch of EU-ME3, a new Endoscopic Ultrasound Processor*, which addresses the needs of healthcare professionals for high-quality clear images when conducting the endoscopic ultrasound procedure.

Key Points: 
  • TOKYO & HAMBURG, Oct 7, 2022 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, today announced the launch of EU-ME3, a new Endoscopic Ultrasound Processor*, which addresses the needs of healthcare professionals for high-quality clear images when conducting the endoscopic ultrasound procedure.
  • Olympus announces the global launch of the EVIS EUS Endoscopic Ultrasound Center EU-ME3.
  • [Image: Olympus Corp]
    As a pioneer in endoscopic ultrasound technology, Olympus aims to leverage its expertise to enhance the care pathway in gastrointestinal and respiratory disease management.
  • The Endoscopic ultrasound procedure typically utilizes a variety of observation modes dependent on procedure type or clinical area.

Georgia Urology expands provider roster by adding three physicians to acclaimed team

Retrieved on: 
Thursday, October 6, 2022
Physician, Incontinence, Vasectomy, DiCarlo, Medicine, Saint Louis University, University, Woman, General surgery, University of Virginia School of Medicine, Laparoscopy, Patient, Green-light, BPH, Erectile dysfunction, Man, American Urological Association, Multimedia, Medical college, Urology, Men's Health, Prostate, DRS, Prostatic urethral lift, Medical College of Georgia, CEO, University of Texas Health Science Center at San Antonio, Health, Pediatrics, Virginia School for Girls, Infertility, Kidney stone disease, Urinary incontinence, Solution, Medical device, Dentistry

ATLANTA, Oct. 6, 2022 /PRNewswire/ -- Georgia Urology – the largest urology practice in Georgia – welcomes Drs. Vincent DiCarlo, Robert Fisher, and Kanika Searvance to its acclaimed team of providers. With this expansion, Georgia Urology continues to provide accessibility and diversity to the array of communities it serves.

Key Points: 
  • ATLANTA, Oct. 6, 2022 /PRNewswire/ -- Georgia Urology the largest urology practice in Georgia welcomes Drs.
  • "At Georgia Urology, our team of talented and enthusiastic medical professionals have a deep passion for patient care and urology," says Dan Fellner, CEO of Georgia Urology.
  • "We're honored to welcome Dr. DiCarlo, Dr. Fisher, and Dr. Searvance to that team, each of whom exemplifies those qualities."
  • Georgia Urology is the largest urology practice in Georgia with more than 30 locations and seven ambulatory surgery centers across metro Atlanta.

Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022

Retrieved on: 
Thursday, September 29, 2022
Therapy, Trial of the century, Incidence, American College, LAR, Company, Health, Colectomy, Laparotomy, Private Securities Litigation Reform Act, NDA, ACS, Forward-looking statement, Patient, Disease, Biology, Standard of care, CA, Nasdaq, Science, Research, GLOBE, Fellowship of the Royal Colleges of Surgeons, Congress, Communication, Laparoscopy, Pharmaceutical industry, Palisade

Details of the abstract presentation are as follows:

Key Points: 
  • Details of the abstract presentation are as follows:
    The abstract is now available and can be accessed in the Congress Program Planner, here .
  • The oral presentation will include new GI functional data sub-cuts from the highly statistically significant Phase 2 clinical study (NCT05056935) demonstrating LB1148 significantly accelerated the return of post-operative GI function in patients undergoing elective bowel resection.
  • The data sub-cuts are based on laparoscopy and laparotomy with surgical characteristics including, right hemicolectomy, left hemicolectomy, sigmoid and low anterior resection (LAR) surgery.
  • Palisade Bio is a late-stage biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier.

Pioneer in the Field of Reproductive Medicine Recognized for Lifetime Achievement

Retrieved on: 
Thursday, September 29, 2022
Olive, Health, BCAHRB Lifetime Achievement Award, Gynaecology, Woman, List of lifetime achievement awards, Elective surgery, Infertility, Gonadotropin, NIPT, Annual general meeting, Shoulder, Fertility, Growth, Nobel, University, TFP, IVF, Patient, Physician, Non-functional testing, General surgery, ART, Genetic testing, Family, Human, Reproductive medicine, Medicine, Laparoscopy, Obstetrics, Paganini Competition, Agriculture, Medical device, Birth control

VANCOUVER, Canada, Sep. 29, 2022 /PRNewswire-PRWeb/ -- Olive Fertility Centre is proud to announce that Dr. Al Yuzpe, co-director and co-founder of Olive Fertility Centre, Chief Medical Officer for The Fertility Partners, and a pioneer in reproductive medicine, received the 2022 Lifetime Achievement Award at the 68th Canadian Fertility and Andrology Society (CFAS) Annual Meeting.

Key Points: 
  • The Lifetime Achievement Award is a special recognition of an individual for extraordinary commitment and proven long-term contributions to the nonprofit CFAS and the field of reproductive science.
  • During his over 50-year career Dr Yuzpe has been internationally recognized for his pioneering work and has helped untold numbers of infertile couples realize their dream of having a family.
  • I am thrilled that he is receiving this prestigious award, as it demonstrates his dedication to the CFAS, as well as the greater field of assisted reproductive technology (ART)."
  • Not only has Dr Yuzpe been a visionary in the field of infertility, he has led the way in making family building accessible to all.

Asensus Surgical Announces St. Bernhard Hospital in Germany to Initiate Senhance Surgery Program

Retrieved on: 
Wednesday, September 28, 2022
Safety, Machine learning, NYSE, Nursing, Sale, Patient, Hospital, Clinic, Bed, ISU, Intelligence, Health, Kamp-Lintfort, Pressure, Catholic (term), Partnership, Deep learning, CEO, Poor Sisters of St. Francis, General officer, Robotics, Surgeon, RESEARCH, Sister, Organ (anatomy), GLOBE, PARK, Laparoscopy, Anatomy, Dentistry, Medical device

We look forward to working with the surgical team to make their Senhance robotic program a success.

Key Points: 
  • We look forward to working with the surgical team to make their Senhance robotic program a success.
  • Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning.
  • In surgical procedures, haptic feedback is a highly sought after feature which is only available on the Senhance Surgical System.
  • This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability.

Global Endoscopy Market Report 2022: Emergence of Capsule Endoscopy Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 15, 2022
Surgery, Health, Other Health, Incidence, Capsule endoscopy, COVID-19, Endoscopy, Olympus Corporation, Risk, Population, Medtronic, Johnson & Johnson, Physician, Ethicon Inc., Arthroscopy, US, Boston Scientific, Hospital, Laparoscopy, Conditional sentence, 3D ultrasound, Fujifilm, CAGR, Medical imaging

The global endoscopy market is predicted to reach US$48.45 billion in 2026, growing at a CAGR of 7.50%, for the duration spanning 2022-2026.

Key Points: 
  • The global endoscopy market is predicted to reach US$48.45 billion in 2026, growing at a CAGR of 7.50%, for the duration spanning 2022-2026.
  • In terms of product, the global endoscopy market can be categorized into endoscopes, visualization systems, endoscopic ultrasound, insufflator and other.
  • According to application, the endoscopy market can be segmented into gastrointestinal endoscopy, laparoscopy, urology endoscopy, arthroscopy and others.
  • The report provides a comprehensive analysis of the global endoscopy market segmented on the basis of product, application, end-user and region.

Olympus Launches New Gynecology Contained Extraction System for Manual Tissue Morcellation

Retrieved on: 
Wednesday, September 14, 2022
Laparoscopy, Olympus, Bleeding, Endoscopy, Abdominal cavity, Hematoma, ASC, Superior, Partnership, Infection, Patient, Technology, Quality of life, Abdominal wall, Cell, Peritonitis, Integration, Surgeon, Method, Percussion section, Multimedia, Pneumoperitoneum, View, Medicine, Morcellator, Dentistry, Medical device, Security printing

CENTER VALLEY, Pa., Sept. 14, 2022 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced today the market launch of the Guardenia™ Contained Extraction System. Guardenia is the latest innovation in their contained tissue extraction product portfolio for gynecological procedures and is manufactured by Advanced Surgical Concepts (ASC) Ltd. of Bray, Ireland. Olympus America Inc. is the exclusive U.S. distributor of the system, which is indicated to contain and isolate tissue during, or prior to, surgical removal and/or extracorporeal manual morcellation.

Key Points: 
  • Guardenia is the latest innovation in their contained tissue extraction product portfolio for gynecological procedures and is manufactured by Advanced Surgical Concepts (ASC) Ltd. of Bray, Ireland.
  • Olympus America Inc. is the exclusive U.S. distributor of the system, which is indicated to contain and isolate tissue during, or prior to, surgical removal and/or extracorporeal manual morcellation.
  • The Guardenia system is designed to prevent the escape of cells into the abdominal cavity during extracorporeal manual morcellation, and its integrated guard provides protection against inadvertent damage from sharp surgical instruments around the incision.
  • Guardenia maximizes the amount of available space in the incision during a procedure by encroaching less into the incision and maintaining a stable protective area to complete manual tissue morcellation.

Olympus Launches VISERA ELITE III Surgical Visualization Platform

Retrieved on: 
Wednesday, September 14, 2022
Medical Supplies, Health, Medical Devices, Hospitals, Surgery, Health Technology, General Health, Laparoscopy, Observation, Software, Olympus, 3D, Efficiency, Gynaecology, Movement, Olympus Corporation, Twitter, Endoscopy, Sale, EDOF, Sony, Blood, Representative, Corporation, Google Images, Patient, Cholecystectomy, Technology, Quality of life, Standard of care, General surgery, EMEA, ENT, Surgeon, Surgical Endoscopy, HCPS, NBI, Hospital, Multimedia, Urology, Medical device

View the full release here: https://www.businesswire.com/news/home/20220913005632/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220913005632/en/
    Surgical visualization platform VISERA ELITE III (Photo: Business Wire)
    With VISERA ELITE III, we provide a best-in-class surgical visualization platform designed for multiple medical specialties and configurations, allowing HCPs to fully focus on the patient during surgery.
  • By incorporating the technologies of its predecessors VISERA ELITE II and VISERA 4K UHD into one platform, VISERA ELITE III enhances the quality of endoscopic surgery, contributes to improved efficiency in the operating room, and hereby elevates the standard of care, said Kanichi Matsumoto, Global Head of Surgical Endoscopy at Olympus.
  • VISERA ELITE III system integrates the 3D and infrared1 imaging functions from VISERA ELITE II, and the 4K imaging function from VISERA 4K UHD system.
  • In developing VISERA ELITE III, Sony Olympus Medical Solutions, a joint venture company of Sony and Olympus, optimized each technology and image processing function specifically for medical applications to create the most advanced, open, and versatile surgical visualization platform Olympus has ever brought to market.

European Patent Office Grants OmniGuide with patent for its Laparoscopic Handpiece for FlexAssure CO2 Flexible Instruments and Fibers

Retrieved on: 
Tuesday, September 13, 2022
Medical Supplies, Medical Devices, Health, Surgery, Other Health, General Health, Intellectual property, OmniGuide, Neurology, European Patent Convention, Patent, European Patent Office, Urology, ENT, Dentistry, Gynaecology, Laparoscopy

Laparoscopy is a surgical approach that allows a surgeon to access the inside of the human body without making large incisions.

Key Points: 
  • Laparoscopy is a surgical approach that allows a surgeon to access the inside of the human body without making large incisions.
  • These procedures are widely adopted worldwide for their patient benefits including smaller surgical scars, quicker recovery, and decreased post procedure pain.
  • OmniGuide FlexAssure CO2 Flexible Instruments are utilized in thousands of surgical procedures including Urology, Gynecology, ENT, and Neurology as well as with handheld, laparoscopic, and surgical robots.
  • We are pleased that the European Patent Office has granted this new patent, in line with our continuous investment in minimally invasive surgery and New Product Development stated Robert Allen, OmniGuide CFO and LISA Laser Products Managing Director OmniGuide has the widest portfolio of CO2 Flexible Instruments and Fibers, uniquely designed to meet minimally invasive surgical needs.